glp-1 receptor agonists and cardiovascular outcome trials an update Glucagon-like peptide 1 agonists: benefits mechanisms of action Real-World Evidence for GLP-1 Receptor
Description
Hair loss concerns have been raised, similar to other aggressive weight loss interventions
Potential winners include drug makers, suppliers and consumer-focused businesses that manufacture healthy foods
10.1111/obr.13177 31
doi: 10.1111/all.14879 [DOI] [PMC free article] [PubMed] [Google Scholar] 146
Am J Hematol
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
